These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9146760)

  • 1. Review article: platelets in inflammatory bowel disease--pathogenetic role and therapeutic implications.
    Collins CE; Rampton DS
    Aliment Pharmacol Ther; 1997 Apr; 11(2):237-47. PubMed ID: 9146760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets circulate in an activated state in inflammatory bowel disease.
    Collins CE; Cahill MR; Newland AC; Rampton DS
    Gastroenterology; 1994 Apr; 106(4):840-5. PubMed ID: 8143990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet dysfunction: a new dimension in inflammatory bowel disease.
    Collins CE; Rampton DS
    Gut; 1995 Jan; 36(1):5-8. PubMed ID: 7890235
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet activity in the pathophysiology of inflammatory bowel diseases.
    Chen C; Li Y; Yu Z; Liu Z; Shi Y; Lewandowska U; Sobczak M; Fichna J; Kreis M
    Curr Drug Targets; 2015; 16(3):219-25. PubMed ID: 25585124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolism in inflammatory bowel disease: role of platelets.
    Webberley MJ; Hart MT; Melikian V
    Gut; 1993 Feb; 34(2):247-51. PubMed ID: 8432482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of inflammation, activation of blood platelets and coagulation disorders in inflammatory bowel diseases.
    Matowicka-Karna J
    Postepy Hig Med Dosw (Online); 2016 Apr; 70():305-12. PubMed ID: 27117106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.
    Voudoukis E; Karmiris K; Koutroubakis IE
    World J Gastroenterol; 2014 Mar; 20(12):3180-90. PubMed ID: 24696603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet activation in inflammatory bowel disease].
    Wu H; Xu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 44(8):931-934. PubMed ID: 31570682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and anticoagulant capacity in patients with inflammatory bowel disease.
    Larsen TB; Nielsen JN; Fredholm L; Lund ED; Brandslund I; Munkholm P; Hey H
    Pathophysiol Haemost Thromb; 2002; 32(2):92-6. PubMed ID: 12214155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulability and Platelet Abnormalities in Inflammatory Bowel Disease.
    Senchenkova E; Seifert H; Granger DN
    Semin Thromb Hemost; 2015 Sep; 41(6):582-9. PubMed ID: 26270113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function and antiplatelet therapy.
    Troxler M; Dickinson K; Homer-Vanniasinkam S
    Br J Surg; 2007 Jun; 94(6):674-82. PubMed ID: 17514662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications.
    Danese S; Motte Cd Cde L; Fiocchi C
    Am J Gastroenterol; 2004 May; 99(5):938-45. PubMed ID: 15128364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets in inflammatory bowel disease.
    Matsumoto T
    J Gastroenterol; 2006 Jan; 41(1):91-2. PubMed ID: 16501865
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial.
    Kulnigg-Dabsch S; Schmid W; Howaldt S; Stein J; Mickisch O; Waldhör T; Evstatiev R; Kamali H; Volf I; Gasche C
    Inflamm Bowel Dis; 2013 Jul; 19(8):1609-16. PubMed ID: 23644823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis. The relationship to thromboembolism.
    Visudhiphan S; Ketsa-Ard K; Piankijagum A; Tumliang S
    Biomed Pharmacother; 1985; 39(6):264-71. PubMed ID: 4084660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets: new players in the mucosal scenario of inflammatory bowel disease.
    Danese S; Scaldaferri F; Papa A; Pola R; Sans M; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):193-8. PubMed ID: 15638229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease.
    Fägerstam JP; Whiss PA; Ström M; Andersson RG
    Inflamm Res; 2000 Sep; 49(9):466-72. PubMed ID: 11071121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation in atherogenesis associated with low-grade inflammation.
    Antoniades C; Bakogiannis C; Tousoulis D; Demosthenous M; Marinou K; Stefanadis C
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):334-45. PubMed ID: 20632958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated platelets in patients suffering from inflammatory bowel disease.
    Tekelioglu Y; Uzun H; Sisman G
    Bratisl Lek Listy; 2014; 115(2):83-5. PubMed ID: 24601701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated platelets and atherosclerosis.
    Aukrust P; Halvorsen B; Ueland T; Michelsen AE; Skjelland M; Gullestad L; Yndestad A; Otterdal K
    Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1297-307. PubMed ID: 20828352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.